Tag: exemestane

Image: PD 1. Exemestane given for prevention of breast cancer in post-menopausal women has limited negative effects on menopause-specific and health-related quality of life. Evidence Rating Level: 1 (Excellent) Study Rundown: Exemestane, a steroidal aromatase inhibitor, was shown in the Mammary Prevention 3 (MAP.3) trial  to reduce the risk of breast cancer...